NY 854457
AUG 08 1990
CLA-2-38:S:N:N1:238 854457
Ms Janet F. Conley
American Laboratory Products Company
PO Box 451
Windham, NH 03087
RE: The tariff classification of five in-vitro diagnostic kits;
ACE (Angiotensin Converting Enzyme), Transcobalamin, Vitamin B6,
Vitamin D3 Screening Kit, and CIC (Circulating Immune Complexes)
from Switzerland.
Dear Ms. Conley:
In your letter dated July 5, 1990 you requested a tariff
classification ruling.
The CIC (Circulating Immune Complexes) research kit is used for
the semi-Quantitative determination of circulating immune complexes
in serum of patients with various autoimmune syndromes and other cic
related diseases. It contains a coating reagent (complement),
microtiter plate, frozen vials of aggregated human IgG calibrator
(antisera) and human serum controls, enzyme- labelled tracer, and
other buffers and substrates.
The applicable subheading for the in-vitro diagnostic kit will be
3822.00.1000, Harmonized Tariff Schedule of the United States (HTS),
which provides for composite diagnostic or laboratory reagents
containing antigens or antisera. The rate of duty will be free.
The other four in-vitro diagnostic kits, to be used for research
purposes, measure vitamin or hormone parameters and contain a
radioactive tracer or enzyme, buffer, calibrator and control serums.
They do not contain any antigens or antisera.
The applicable subheading for the four kits, ACE (Angiotensin
Converting Enzyme), Transcobalamin, Vitamin B6, and Vitamin D3
Screening Kit will be 3822.00.5000, Harmonized Tariff Schedule of the
United States (HTS), which provides for other, composite diagnostic or
laboratory reagents. The rate of duty will be 5 percent ad valorem.
This merchandise may be subject to the regulations of the Food and
Drug Administration. You may contact them at 5600 Fishers Lane,
Rockville, Maryland 20857, telephone number (202) 443-3380.
This ruling is being issued under the provisions of Section 177 of
the Customs Regulations (19 C.F.R. 177).
A copy of this ruling letter should be attached to the entry
documents filed at the time this merchandise is imported. If the
documents have been filed without a copy, this ruling should be brought
to the attention of the Customs officer handling the transaction.
Sincerely,
Jean F. Maguire
Area Director
New York Seaport